CD19‐CAR T‐cell therapy with sorafenib in post‐<scp>HSCT</scp> relapse of mixed phenotype acute leukaemia (<scp>MPAL</scp>) with phenotypic myeloid to lymphoid lineage switch—A case report and review of the literature-Reference-Cited by-同舟云学术

CD19‐CAR T‐cell therapy with sorafenib in post‐HSCT relapse of mixed phenotype acute leukaemia (MPAL) with phenotypic myeloid to lymphoid lineage switch—A case report and review of the literature

Published:2024-06-26 Issue: Volume: Page:
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Oszer A.¹^ORCID,Kołodrubiec J.¹,Pawlik B.¹²,Marschollek P.³,Ćwilichowska N.⁴,Jakubowska J.¹,Bukowska‐Strakova K.⁵,Surman M.⁵,Trelińska J.¹,Miarka‐Walczyk K.¹⁶,Haze N.³,Liszka K.³,Mielcarek‐Siedziuk M.³,Kałwak K.³,Poręba M.⁴,Pastorczak A.¹⁶^ORCID,Janczar S.¹,Młynarski W.¹

Affiliation:

1. Department of Pediatrics, Oncology and Hematology Medical University of Lodz Lodz Poland

2. Postgraduate School of Molecular Medicine Medical University of Warsaw Warsaw Poland

3. Department of Pediatric Bone Marrow Transplantation, Oncology, and Hematology Wroclaw Medical University Wroclaw Poland

4. Department of Chemical Biology and Bioimaging, Faculty of Chemistry Wroclaw University of Science and Technology Wroclaw Poland

5. Department of Clinical Immunology, Institute of Pediatrics Jagiellonian University Medical College Krakow Poland

6. Department of Genetic Predisposition to Cancer Medical University of Lodz Lodz Poland

Funder

Narodowe Centrum Nauki

Agencja Badań Medycznych

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.19608

Reference15 articles.

1. Pediatric Mixed-Phenotype Acute Leukemia: What’s New?

2. Blinatumomab for paediatric mixed phenotype acute leukaemia

3. Secondary donor‐derived humanized CD19‐modified CAR‐T cells induce remission in relapsed/refractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report;Li MY;Biomark Res,2020